3 completed, 2 terminated, 2 unknown, 1 not yet recruiting. 7 Phase 2, 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 2, Terminated 2, Unknown 2, Recruiting 1 |
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Botulinum Neurotoxin Type A: new trials by email Literature Review of Botulinum Neurotoxin Type A trials Research Report on Botulinum Neurotoxin Type A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DaxibotulinumtoxinA for Blepharospasm Botulinum Neurotoxin Type A - Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid | Phase 2 | Recruiting | University of Pennsylvania | 20 | 2026-09-24 | 2026-09-29 |
| Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies Botulinum Neurotoxin Type A, Non-pharmacological therapies - Spasticity | Not applicable | Not yet recruiting | Technical University of Bern | 30 | 2025-10-01 | 2025-09-08 |
| Study of the Drug B11-FC (Botulism Treatment) B11-FC, Botulinum neurotoxin type A, Placebo - Botulism | Phase 1 / Phase 2 | Unknown | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 40 | 2024-08-01 | 2024-08-30 |
| Arthrocentesis-PRF Versus Botulinum Toxin for Management of ADDwR Injectable Platelet-Rich Fibrin (I-PRF) Injection, Botulinum Toxin Type A (BOTOX) Injection - Temporomandibular Joint Internal Derangement, Temporomandibular Joint Disorders | Not applicable | Completed | Suez Canal University | 20 | 2024-01-10 | 2026-10-07 |
| Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy Botulinum Toxin Type A - Pancreatic Carcinoma | Phase 2 | Terminated | OHSU Knight Cancer Institute | 4 | 2023-03-01 | 2025-05-13 |
| Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer Botulinum Toxin Type A, Esophagectomy, Quality-of-Life Assessment - Esophageal Carcinoma | Phase 2 | Completed | Roswell Park Cancer Institute | 33 | 2016-12-30 | 2023-02-16 |
| Botulinum Toxin in Burning Mouth Syndrome Botulinum Neurotoxin Type A, Normal saline - Burning Mouth Syndrome | Phase 2 | Completed | Presidio Ospedaliero Garibaldi-Centro | 6 | 2015-11-01 | 2016-12-07 |
| Kinematic-guided BoNT-A Treatment for ET and PD Tremor BoNT-A - Tremor | Phase 2 | Unknown | Western University, Canada | 54 | 2011-10-01 | 2019-08-20 |
| Safety and Efficacy of the Use of Botox on Acne Botulinum Neurotoxin Type A, Bacteriostatic saline - Acne Vulgaris | Phase 2 | Terminated | DeNova Research | 5 | 2008-09-01 | 2018-06-29 |
Acne Vulgaris (1) · Benign essential blepharospasm (1) · Blepharospasm (1) · Botulism (1) · Burning Mouth Syndrome (1) · Dystonia (1) · Esophageal Neoplasms (1) · Muscle Spasticity (1) · Pancreatic Neoplasms (1) · Parkinsonian Disorders (1) · Temporomandibular Joint Disorders (1) · Tremor (1)
DeNova Research (1) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1) · OHSU Knight Cancer Institute (1) · Presidio Ospedaliero Garibaldi-Centro (1) · Roswell Park Cancer Institute (1) · Suez Canal University (1) · Technical University of Bern (1) · University of Pennsylvania (1) · Western University, Canada (1)
United States (4) · Egypt (1) · Switzerland (1) · United Kingdom (1)
Brett C Sheppard, M.D., FACS (1) · Mandar Jog, MD, FRCPC (1) · Margret Hund-Georgiadis, PD Dr.med. (1) · Mohamed Said Hamed, Professor (1) · Moshim Kukar (1) · Steven H Dayan, MD F.A.C.S. (1)
PMID 12963779, PMID 15911160, PMID 18546285, PMID 27101283
2025 (1)